A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis. - BECAUSE - Betaferon in Early SPMS - SCAndinavian study on USE of double dose
A Pilot Study to Evaluate the Safety of Subcutaneous Alemtuzumab (MabCampath, Campath) in Patients With B-Cell Chronic Lymphocytic Leukemia
This is a Phase II trial to study the safety and tolerability of subcutaneous alemtuzumab administered without dose escalation to patients with advanced B-cell chronic lymphocytic leukemia (B-CLL).
100 Clinical Results associated with Schering Nordiska AB
0 Patents (Medical) associated with Schering Nordiska AB
01 Jan 1976·Acta Obstetricia et Gynecologica Scandinavica, Supplement
Estrogens and thromboembolic diseases. Present conception of a controversial issue
Review
Author: Zador, Goran
A review with 64 references on the usage of estrogen-containing contraceptives and the incidence of thromboembolic diseases.
100 Deals associated with Schering Nordiska AB
100 Translational Medicine associated with Schering Nordiska AB